Gabriela Michell Mendoza Martinez, | |
1457 Nc Highway 111 S, Goldsboro, NC 27534-6964 | |
(919) 223-4505 | |
Not Available |
Full Name | Gabriela Michell Mendoza Martinez |
---|---|
Gender | Female |
Speciality | Social Worker - Clinical |
Location | 1457 Nc Highway 111 S, Goldsboro, North Carolina |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1144893769 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YA0400X | Counselor - Addiction (substance Use Disorder) | (* (Not Available)) | Secondary |
1041C0700X | Social Worker - Clinical | PO15216 (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Gabriela Michell Mendoza Martinez, 1457 Nc Highway 111 S, Goldsboro, NC 27534-6964 Ph: () - | Gabriela Michell Mendoza Martinez, 1457 Nc Highway 111 S, Goldsboro, NC 27534-6964 Ph: (919) 223-4505 |
News Archive
A report released on Sunday by a task force of the Association of American Medical Colleges that recommends new restrictions on what physicians, staff members and students at U.S. medical schools can accept from drug companies and medical device makers is "encouraging," but it "flinched" on some important issues, a New York Times editorial states (New York Times, 4/29).
Massage is commonly regarded as a therapy associated with relieving muscle tension and pain.
A research team led by Anastassios G. Pittas, MD, MS, Endocrinologist and Co-Director of the Diabetes Center at Tufts Medical Center in Boston, has received a National Institutes of Health grant of more than $40 million over five years to conduct the Vitamin D and Type 2 diabetes study.
Sage Science, Inc. announced today the release of the Pippin Prep DNA size selection system to the United States market. This device automates the collection of DNA fragments for next generation sequencing library preparations, and replaces manual gel purification techniques that typically require hours of effort.
Pacific Beach BioSciences, Inc. today reported that it has granted non-exclusive rights to a large pharmaceutical company for the use of one of its anti-fungal compounds required for the manufacturing of a clinical stage product.
› Verified 1 days ago